The pharmaceutical giant has developed a cloud solution for continuously ingesting, visualizing, and transforming digital biomarker data into meaningful medical insights.
The administration doesn't expect to finalize contracts with pharmacies distributing the vaccine to the uninsured until mid-October, weeks after the shot is made widely available.